Information about Danis Pharma
My details
*
*
*

Danis Pharma (SA)

Company information

Status
Active

Enterprise number

BE0465.345.721

VAT liability
Yes
Established
22-01-1999
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Danis Pharma

2024 2023 2022 2021
Profit/Loss 82,319 13 % 73,067 -28 % 100,954 4 % 97,498
Equity 712,381 13 % 630,062 13 % 556,995 22 % 456,041
Gross margin 124,638 5 % 118,241 -26 % 158,993 -2 % 162,510

Publications from Danis Pharma

Date Publication
16-01-2024 Modification(s) Articles of Association (NL)
26-06-2019 Resignations - Appointments (NL)
15-02-2012 Capital - Shares - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
15-02-2010 Resignations - Appointments (NL)
09-12-1999 Registered Office Relocation (NL)

Frequently asked questions

What is the VAT number of Danis Pharma?
The VAT number of Danis Pharma is BE 0465.345.721.
Wat is the PEPPOL ID of Danis Pharma?
There is no information available about the PEPPOL ID of Danis Pharma or the company is not yet registered on the PEPPOL network.
When was Danis Pharma founded?
Danis Pharma was founded on 22-01-1999.
What is the address of Danis Pharma?
The current registered office of Danis Pharma is located at Danislaan 13, 1650 Beersel.
When was the last time Danis Pharma filed their annual financial statements?
The most recent financial statements of Danis Pharma were filed on 23-02-2025.
How many employees does Danis Pharma have?
There are currently no employees working at Danis Pharma or no workforce information is available.
What is the annual turnover of Danis Pharma?
At the time of its most recent financial statements, Danis Pharma did not publish any turnover figures. Danis Pharma reported a gross margin of €124,637.88.